COMMUNIQUÉS West-GlobeNewswire

Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS), today announced that its second quarter 2026 financial results will be released on Wednesday, August 5, 2026. Starting at 5 [...]
Egg Medical Declares New Era in Fluoroscopy Lab Safety Following Joint Consensus Statement
22/07/2026
As major medical societies call for mandatory adoption of Enhanced Radiation Protection Devices (ERPDs), the EggNest® Complete system emerges as the definitive solution to protect the entire clinical team MINNEAPOLIS, [...]
Serenity Medical’s River Stent™ Demonstrates Sustained 4- to 5-Year Benefits in Patients with Idiopathic Intracranial Hypertension (IIH), Presented at SNIS Annual Meeting in Late-Breaking Session
22/07/2026
Long-term data reinforce durability of venous sinus stenting as an evidence-backed, FDA-approved treatment option MAPLE GROVE, Minn., July 22, 2026 (GLOBE NEWSWIRE) -- Serenity Medical , a NeuroTechnology Investors (NTI [...]
The Healing Well Method Launches Chronic Illness Education Initiative to Empower Women with Chronic Illness
22/07/2026
Fort Lauderdale, FLORIDA, July 22, 2026 (GLOBE NEWSWIRE) -- The Healing Well Method today announced the launch of its Chronic Illness Education Initiative, a new educational program designed to help women living with [...]
OKYO Pharma Announces Purchase of Shares by Chairman
22/07/2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
One Tulsa Physician Manages Hormone Therapy, Peptides and GLP-1 Weight Loss
22/07/2026
Results Medical Aesthetics & Wellness, a physician-led clinic in Tulsa, prescribes hormone replacement therapy only after comprehensive lab testing establishes a metabolic baseline. Laura Bilbruck, MD, an Oklahoma- [...]
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 août 2026
22/07/2026
Lyon (France), le 22 juillet 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui qu’elle publiera ses résultats financiers du premier semestre le jeudi 13 [...]
NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform
22/07/2026
Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services, pharmaceutical access, lab testing, institutional partnerships, [...]
RAMSAY SANTE : Press Release - Refinancing new steps forward
22/07/2026
PRESS RELEASE Paris, 22 nd July 2026 New steps in connection with Ramsay Santé contemplated free-float expansion: Ramsay Santé successfully completes its senior debt refinancing and convenes a Capital Markets Day on 17 [...]
Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026
22/07/2026
CORRECTIVE STATEMENT Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026, published on July 9, 2026 Paris, July 22, 2026 This corrective statement is [...]
Spryte Medical Completes INSYTE Trial Enrollment
22/07/2026
FDA-approved IDE study of the company’s neuro-optical coherence tomography nOCT™ Imaging System completes enrollment, representing a significant step toward regulatory submission for diagnostic use in intracranial [...]
RAMSAY SANTE : communiqué de presse - refinancement et prochaines étapes
22/07/2026
COMMUNIQUÉ DE PRESSE Paris, le 22 juillet 2026 Ramsay Santé franchit de nouvelles étapes dans le cadre de l’élargissement envisagé de son flottant : succès du refinancement de sa dette senior et organisation d’un [...]
FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food
22/07/2026
Silver Spring, MD, July 22, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to Make [...]
Ipsen - Déclaration rectificative corrigeant la déclaration mensuelle du nombre total d'actions et de droits de vote au 30 juin 2026
22/07/2026
DÉCLARATION RECTIFICATIVE Déclaration rectificative corrigeant la déclaration mensuelle du nombre total d'actions et de droits de vote au 30 juin 2026, publiée le 9 juillet 2026 Paris, le 22 juillet 2026 La présente [...]
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
22/07/2026
Lyon (France), July 22, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its first half 2026 financial results on Thursday, August 13, 2026. The [...]
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
22/07/2026
BOSTON, July 22, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
22/07/2026
BRISBANE, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, [...]
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
22/07/2026
New AMA Category III codes, effective July 1, 2026, support the development of future reimbursement pathways for temporary transvenous diaphragm neurostimulation EXTON, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Lungpacer [...]
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
22/07/2026
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint. 14 patients with available data from six-month follow-up and biopsy show preliminary 86% (12/14) [...]

Pages